Eight Cases of Hypocalcemia Induced by Tigecycline

doi:10.19803/j.1672-8629.2021.01.15

Abstract

Abstract: Objective To improve the safety of clinical use of tigecycline.Methods Patients with hypocalcemia caused by tigecycline were screened from July 1,2018 to June 30,2019 with active monitoring software for adverse reactions before data was analyzed using electronic medical records and adverse reaction criteria.Results The use of tigecycline was associated with hypocalcemia.Conclusion It is recommended that the monitoring of serum calcium be enhanced when tigecycline is used in clinic.

Key words: tigecycline, hypocalcemia, adverse drug reaction

CLC Number:

R994.11

TAO Hong, SHEN Zhu, CAO Guowen, SHI Aiming, PAN Jie. Eight Cases of Hypocalcemia Induced by Tigecycline[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 77-79.

References

[1] Wenzel R,Bate G,Kirkpatrick P.Tigecycline[J].Nat Rev Drug Discov,2005,4(10):809-810.
[2] Bergeron J,Ammirati M,Danley D,et al.Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection[J].Antimicrob Agents Chemother,1996,40(9):2226-2228.
[3] Hu F,Guo Y,Yang Y,et al.Resistance reported from China antim-icrobial surveillance network (CHINET) in 2018[J].Eur J Clin Microbiol Infect Dis,2019,38(12):2275-2281.
[4] Kaewpoowat Q,Ostrosky-Zeichner L.Tigecycline :a critical safety review[J].Expert Opin Drug Saf,2015,14(2):335-342.
[5] Yamashita N,Matschke K,Gandhi A,et al.Tigecycline pharmacokinetics,tolerability,safety,and effect on intestinal microflora in healthy Japanese male subjects[J].J Clin Pharmacol,2014,54(5):513-519.
[6] Chen XX,Zhou XF,Quan QX,et al.Adverse reaction monitoring of patients with multi-drug resistant bacteria infection treated by tigecycline in ICU[J].Journal of Nursing(China)(护理学报),2012,19(11A):59-61.
[7] Jiang YN,Zhao ZG.Prevention and treatment of tumor lysis syndrome[J].J Clin Intern Med(临床内科杂志),2018,35(9):593-595.
[8] Riley MM.The rising problem of multidrug-resistant organisms in intensive care units[J].Crit Care Nurse,2019,39(4):48-55.
[9] He H,Zheng Y,Sun B,et al.Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii[J].J Thorac Dis,2016,8(10):2784-2792.
[10] Xu Y,Jin L,Liu N,et al.Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit[J].Int J Infect Dis,2019(82):79-85.
[11] Corsonello A,Abbatecola AM,Fusco S,et al.The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly[J].Clin Microbiol Infect,2015,21(1):20-26.
[12] De Pascale G,Montini L,Pennisi M,et al.High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria[J].Crit Care,2014,18(3):R90.
[13] Ramirez J,Dartois N,Gandjini H,et al.Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia[J].Antimicrob Agents Chemother,2013,57(4):1756-1762.
[14] de Brito Galvo JF,Schenck PA,Chew DJ.A quick reference on hypocalcemia[J].Vet Clin North Am Small Anim Pract,2017,47(2):249-256.
[15] Wang FF,Chen WH,He ZQ,et al.Analysis of literature and clinical cases of adverse drug reactions induced by zoledronic acid injection[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(4):223-227.